NT5E CpG island methylation is a favourable breast cancer biomarker.
about
The roles of CD73 in cancerClinical significance of methylation of E-cadherin and p14ARF gene promoters in skin squamous cell carcinoma tissues.Combining phenotypic and proteomic approaches to identify membrane targets in a 'triple negative' breast cancer cell typeGenetic variation in the adenosine regulatory cycle is associated with posttraumatic epilepsy developmentSubpathway-GMir: identifying miRNA-mediated metabolic subpathways by integrating condition-specific genes, microRNAs, and pathway topologiesCD73 promotes anthracycline resistance and poor prognosis in triple negative breast cancerDNA methylation in ductal carcinoma in situ of the breast.CD73/NT5E is a target of miR-30a-5p and plays an important role in the pathogenesis of non-small cell lung cancer.Epigenetic Biomarkers of Breast Cancer Risk: Across the Breast Cancer Prevention Continuum.Targeting CD73 and downstream adenosine receptor signaling in triple-negative breast cancer.CD73-adenosine: a next-generation target in immuno-oncology.CD73s protection of epithelial integrity: Thinking beyond the barrier.Anti-CD73 therapy impairs tumor angiogenesis.
P2860
Q34003164-E2730916-CB77-4D65-9308-303A3E82F4FEQ34042261-1B24A166-B9AE-4FEF-985B-3EF483213343Q34584880-CCBEFD08-CAB3-486C-809E-CA6EAEECBD5BQ35911926-354AC3B7-1A8F-4EA2-8DAD-FB98ED699933Q36629543-619750E6-8313-41FF-96FA-BF503DE372D2Q36991010-17A175A6-2FCC-45B3-BC03-FE85F7C1AC48Q36998647-5DBE3A16-A0A2-4019-8E15-7344750BD1A5Q37624627-FC4A93DF-53C9-4B9D-A2D1-6A8C16C2E7F0Q37639092-0E65AB52-B279-492E-839E-2D4D8A94C6F1Q38209586-97BAAA78-BD7D-4C14-9510-18F43C7E8CF1Q38711094-068B5316-D60D-465D-9ACD-9E6DEB7DBF10Q40783577-E6B71052-2EBD-4238-9B87-B7DD7CC9E932Q45737780-24E5C669-CBA9-43FD-BDCB-20AEE5B56C35
P2860
NT5E CpG island methylation is a favourable breast cancer biomarker.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
NT5E CpG island methylation is a favourable breast cancer biomarker.
@ast
NT5E CpG island methylation is a favourable breast cancer biomarker.
@en
type
label
NT5E CpG island methylation is a favourable breast cancer biomarker.
@ast
NT5E CpG island methylation is a favourable breast cancer biomarker.
@en
prefLabel
NT5E CpG island methylation is a favourable breast cancer biomarker.
@ast
NT5E CpG island methylation is a favourable breast cancer biomarker.
@en
P2093
P2860
P356
P1476
NT5E CpG island methylation is a favourable breast cancer biomarker.
@en
P2093
A Thompson
C Lo Nigro
C Palmieri
E Briasoulis
E Hatzimichael
P2860
P2888
P356
10.1038/BJC.2012.212
P407
P577
2012-05-31T00:00:00Z